Europe
Even with a holiday week, July 4, there were a number of clinical trial reports. Here’s a look.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
According to a University College London (UCL) report, British researchers are being shut out of major European research partnerships because of concerns over a no-deal Brexit.
Fusion Antibodies plc announces its final results for the year ended 31 March 2019.
Patented technology applied in SynGEM, a needle-free nasal spray vaccine against respiratory syncytial virus * Re-Issuance of U.S. Patent No. RE 47,471 further bolsters Mucosis’ intellectual property portfolio
Agreement will cover development and marketing of oncolytic virotherapies
BioArctic AB to publish the company’s Interim Report for the period January – June 2019 on Thursday, July 11, 2019 at 08:00 a.m. CET.
Former founding managing director of JDRF T1D Fund joins DDF leadership team
Cancers with the same genetic weaknesses respond differently to targeted drugs depending on the tumour type of the patient, new research reveals.
Chignolo D’Isola, Bergamo, Italy – July 1, 2019 – Flamma SpA, a preeminent Contract Development and Manufacturing Organization that develops, manufactures, and commercializes small molecule Active Pharmaceutical Ingredients for the pharmaceutical industry, is proud to announce that the company has acquired the Teva’s Chemical Synthesis Center in Malvern, PA in the Philadelphia area.
PRESS RELEASES